Open official notice

太陽堂製薬株式会社 "Medicine: Aogusuri Tablets" - Recall

Official notice

27 Mar 2003

Last checked

28 Oct 2026

RecallScope risk estimate:HighCAA Japan

An official CAA Japan notice concerns 太陽堂製薬株式会社 "Medicine: Aogusuri Tablets" - Recall. We have decided to conduct a voluntary recall because the Scopolia extract used as a raw material in this product was found to have been produced by the raw material manufacturer using a method different from that specified in the manufacturing approval document (ethanol extraction → methanol extraction). [Specific potential health harm] The product meets the specifications of its manufacturing approval. No reports of health harm have been received to date. Published 2003-03-27.

What to do now

We have identified all locations supplied through the household medicine placement sales system. We will notify placement sales distributors and others in writing and arrange for placement sales staff to visit each household to collect the products.

Official notice

2003-03-27

The hazard

We have decided to conduct a voluntary recall because the Scopolia extract used as a raw material in this product was found to have been produced by the raw material manufacturer using a method different from that specified in the manufacturing approval document (ethanol extraction → methanol extraction). [Specific potential health harm] The product meets the specifications of its manufacturing approval. No reports of health harm have been received to date.

How to check if you're affected

Product identifiers are not currently available in RecallScope. Check the official notice before deciding whether your item is affected.

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

医薬品 青ぐすり「錠剤」

Hazard

We have decided to conduct a voluntary recall because the Scopolia extract used as a raw material in this product was found to have been produced by the raw material manufacturer using a method different from that specified in the manufacturing approval document (ethanol extraction → methanol extraction). [Specific potential health harm] The product meets the specifications of its manufacturing approval. No reports of health harm have been received to date.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

JP · Japan

Affected area 1

JP · Japan

Company & contacts

Brand

太陽堂製薬

Manufacturer

太陽堂製薬株式会社

Phone

Not provided

Brand: 太陽堂製薬. Contact: 太陽堂製薬株式会社.

Source & status

Source

Tier

official

Category

HEALTH

Official classification

消費者庁 — 回収

Recall details

Event id

CAA-00000002560

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 27 Mar 2003. The next one won't wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button